Evaluating the Cost-effectiveness of Catheter Ablation of Atrial Fibrillation

被引:16
作者
Chang, Andrew Y. [1 ]
Kaiser, Daniel [1 ]
Ullal, Aditya [2 ]
Perino, Alexander C. [1 ,2 ]
Heidenreich, Paul A. [1 ,2 ]
Turakhia, Mintu P. [1 ,2 ]
机构
[1] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[2] Vet Affairs Palo Alto Hlth Care Syst, Livermore, CA 94550 USA
关键词
Atrial fibrillation; catheter ablation; cost-effectiveness; health policy; review;
D O I
10.15420/aer.2014.3.3.177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation (AF) is one of the most common cardiac conditions treated in primary care and specialty cardiology settings, and is associated with considerable morbidity, mortality and cost. Catheter ablation, typically by electrically isolating the pulmonary veins and surrounding tissue, is more effective at maintaining sinus rhythm than conventional antiarrhythmic drug therapy and is now recommended as first-line therapy. From a value standpoint, the cost-effectiveness of ablation must incorporate the upfront procedural costs and risks with the benefits of longer term improvements in quality of life (QOL) and healthcare utilisation. Here, we present a primer on cost-effectiveness analysis (CEA), review the data on cost-effectiveness of AF ablation and outline key areas for further investigation.
引用
收藏
页码:177 / 183
页数:7
相关论文
共 43 条
[1]   The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy [J].
Aronsson, Mattias ;
Walfridsson, Hakan ;
Janzon, Magnus ;
Walfridsson, Ulla ;
Nielsen, Jens Cosedis ;
Hansen, Peter Steen ;
Johannessens, Arne ;
Raatikainen, Pekka ;
Hindricks, Gerhard ;
Kongstad, Ole ;
Pehrson, Steen ;
Englund, Anders ;
Hartikainen, Juha ;
Mortensen, Leif Spange ;
Levin, Lars-Ake .
EUROPACE, 2015, 17 (01) :48-55
[2]  
Assasi N, 2010, 128 CAN AG DRUGS TEC
[3]  
Blackhouse G, 2013, INT J VASC MED, V2013, DOI [10.1155/2013/262809, 10.1155/2013/62809]
[4]   Pulmonary vein ablation for idiopathic atrial fibrillation: six month outcome of first procedure in 100 consecutive patients [J].
Bourke, JP ;
Dunuwille, A ;
O'Donnell, D ;
Jamieson, S ;
Furniss, SS .
HEART, 2005, 91 (01) :51-57
[5]   The estimation of a preference-based measure of health from the SF-36 [J].
Brazier, J ;
Roberts, J ;
Deverill, M .
JOURNAL OF HEALTH ECONOMICS, 2002, 21 (02) :271-292
[6]  
Brazier J, MED CARE
[7]   Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation Two Systematic Literature Reviews and Meta-Analyses [J].
Calkins, Hugh ;
Reynolds, Matthew R. ;
Spector, Peter ;
Sondhi, Manu ;
Xu, Yingxin ;
Martin, Amber ;
Williams, Catherine J. ;
Sledge, Isabella .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (04) :349-U49
[8]   Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation [J].
Cappato, R ;
Calkins, H ;
Chen, SA ;
Davies, W ;
Iesaka, Y ;
Kalman, J ;
Kim, YH ;
Klein, G ;
Packer, D ;
Skanes, A .
CIRCULATION, 2005, 111 (09) :1100-1105
[9]   Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation [J].
Cappato, Riccardo ;
Calkins, Hugh ;
Chen, Shih-Ann ;
Davies, Wyn ;
Iesaka, Yoshito ;
Kalman, Jonathan ;
Kim, You-Ho ;
Klein, George ;
Natale, Andrea ;
Packer, Douglas ;
Skanes, Allan ;
Ambrogi, Federico ;
Biganzoli, Elia .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2010, 3 (01) :32-38
[10]   Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation [J].
Chan, Paul S. ;
Vijan, Sandeep ;
Morady, Fred ;
Oral, Hakan .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (12) :2513-2520